Skip to main content
NMRA
NASDAQ Life Sciences

Neumora Posts $34.4M Q3 Loss, $85.7M Cash, Skips Runway Guidance

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.421
Mkt Cap
$80.589M
52W Low
$0.315
52W High
$3.65
52W Position info
33% above low
Off High info
88% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

NMRA sits 33% above its 52-week low of $0.315 on light trading volume (0.3× avg).

Summary

Neumora ended Q3 with $85.7 million in cash and a $34.4 million net loss, down from $56.8 million a year ago as R&D spending fell to $22.6 million from $40.5 million, with a third-quarter loss per share of 18 cents. The company declined to give updated runway guidance and said it will need substantial additional funding, with the 10-Q flagging going-concern doubt. Pipeline updates: an IND was submitted for NMRA-215 in obesity, and the 30 mg BID NMRA-511 cohort showed no serious adverse events with dose-proportional exposure, making that program Phase 2 enabled. The cash burn versus a roughly $81 million market cap keeps dilution risk front and center, and the October 26 Nasdaq minimum-bid notice adds a listing overhang. No specific date was given for the next data readout.

At the time of this announcement, NMRA was trading at $0.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $80.6M. The 52-week trading range was $0.32 to $3.65. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NMRA - Latest Insights

NMRA
Nov 16, 2026, 8:15 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.4206
Real-time Price: $0.38615 info
Change: -$0.03445 (-8%) info
Market Cap: $73.42M info
NMRA
Nov 16, 2026, 8:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4206
Real-time Price: $0.38615 info
Change: -$0.03445 (-8%) info
Market Cap: $73.42M info
NMRA
Oct 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3672
Real-time Price: $0.38615 info
Change: +$0.01895 (+5%) info
Market Cap: $73.42M info
NMRA
Aug 14, 2026, 7:23 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.65
Real-time Price: $0.38615 info
Change: -$1.26 (-77%) info
Market Cap: $73.42M info
NMRA
Aug 14, 2026, 7:13 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $0.38615 info
Change: -$1.26 (-77%) info
Market Cap: $73.42M info